A user expressed dissatisfaction with the GLOW blend (BPC-157/TB-500/GHK-Cu), arguing that the ratios make it difficult to achieve an effective dose of recovery peptides without overdosing on GHK-Cu. They noted that higher therapeutic doses for serious tendon tears are not feasible with this specific pre-mixed formulation.